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INTRODUCTION
The Latvian medicine reimbursement system for outpatient
treatment has developed starting from the 1990s. The 2006
Regulations No. 899 of the Cabinet of Ministers of the Re-
public of Latvia, ”Procedures for the Reimbursement of Ex-
penditures for the Acquisition of Medicinal Products and
Medicinal Devices Intended for Out-patient Medical Treat-
ment” (hereafter – Regulations No. 899), regulate this sys-
tem at the present. The procedures for reimbursement are a
set of measures that provide patients with an opportunity to
acquire medicinal products and medical devices, the expen-
ditures for the acquisition of which are completely or par-
tially covered by funds from the state budget for the current
year, granted for the reimbursement of expenditures for the
acquisition of medicinal products in accordance with these
regulations, or by the funds granted in accordance with the
Social Security Network Strategy (Anonymous, 2006).
Nineteen groups of diagnoses are reimbursed in accordance
with the Regulations No. 899 (groups of diagnoses are clas-
sified by the International Statistical Classification of Dis-
eases and Relates Health Problems 10th Revision (ICD-10)).
Expenditures for the reimbursement of medicinal products
are covered under the following reimbursement categories
(Anonymous, 2006):
• Category I – reimbursement in the amount of 100%, if it
has been determined that a patient has a chronic, life-
threatening disease or a disease, which causes serious ir-
reversible disability and the medical treatment of which
requires the use of the respective medicinal products in
order to maintain the patient’s vital functions;
• Category II – reimbursement in the amount of 75%, if it
has been determined that a patient has a chronic disease,
in the medical treatment of which the maintenance of the
patient’s vital functions is made difficult or which causes
serious disability without the use of the respective medic-
inal products; and
• Category III – reimbursement in the amount of 50%, if it
has been determined that a patient has a chronic or acute
disease, in the medical treatment of which the use of the
respective medicinal products is necessary in order to
maintain or improve the patient’s state of health or in the
case where vaccines are paid for from the funds granted
for reimbursement.
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In Latvia, the medicine reimbursement system for outpatient treatment operates under conditions
of limited resources, and the state budget financing has been reduced in recent years. Under
such circumstances, a necessity to identify additional possibilities to optimise resources allocation
to health care programmes and prevention activities is important. The aim of this research was to
identify nutrition-related diagnoses in the Latvian medicine reimbursement system and to deter-
mine potential efficiency of the resource allocation to complementary nutrition programmes. To
meet the aim defined, theoretical research methods (analysis of legislative documents and spe-
cial literature analysis) were used alongside empirical research methods (data collection: docu-
mentary analysis, statistical database analysis). The results of this research showed that the
largest amount of reimbursed diagnoses, such as cardiovascular diseases, diabetes, cancer, di-
gestive diseases, and osteoporosis, are identified as nutrition-related diagnoses in the review of
special literature. Determination of the efficiency of complementary nutrition programmes is a cru-
cial issue in the context of the evidence-based medicine, both in terms of direct and indirect costs
to society and government, and in terms of disability-adjusted life years and other health determi-
nants directly related to patients. For this reason, possibilities for the evaluation of relative effi-
ciency of the nutrition programmes for reimbursed diagnoses are investigated in depth.
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The number of patients treated through the reimbursement
system has increased yearly (Fig. 1). The biggest number of
patients is treated through the reimbursement system in the
group of diagnoses “Diseases of the circulatory system”,
“Endocrine, nutritional and metabolic diseases” and “Dis-
eases of the respiratory system”, and the number of patients
is rising annually (excluded diagnoses “Mental and behav-
ioural disorders” in which the number of patients has de-
clined in 2011) (Fig. 2).
In spite of a relatively low number of patients with diseases
of the digestive system, this group is one of the more impor-
tant in mortality data (Table 1). Table 1 includes data of
mortality in Latvia and in neighbouring Baltic States.
The largest part of the health care budget resourses for the
reimbursement system is allocated for diseases of the circu-
latory system, endocrine, nutritional und metabolic diseases
and neoplasms (Fig. 3). However, the data on total expendi-
ture for reimbursed medicinal products (budget allocation
and patients’ co-payment) show that the patients’ co-
payment has increased in circumstances of reduced budget
allocation, as the need for treatment, based on growing pa-
tients number, increases independently of budget resources
allocated (Fig. 4). In these circumstances, taking into ac-
count the limited state budget for the medicine reimburse-
ment system and patient resources, the aim of this research
was to identify additional possibilities to optimise resource
allocation to the health care, based on nutrition-related diag-
noses in the medicine reimbursement system and potential
efficiency of complementary nutrition programmes.
MATERIALS AND METHODS
To meet the aim defined, theoretical research methods
(analysis of legislation, special literature analysis and analy-
sis of electronic resources) were used alongside empirical
research methods (data collection: document analysis, sta-
tistical database analysis). For data processing and analysis,
statistical analysis methods (comparison, grouping, calcula-
tion of averages) and methods of economic analysis were
used.
T a b l e 1
DEATHS BY CAUSE PER 100 000 POPULATION IN ESTONIA, LAT-
VIA AND LITHUANIA BY MAJOR GROUPS OF CAUSES (Anony-
mous, 2010)
Cause of death Deaths by cause per 100 000
population in Baltic States
Estonia Latvia Lithuania
Diseases of the circulatory system 652.9 727.1 718.8
Neoplasms 269.0 273.6 251.2
Injury, poisoning and certain other
consequences of external causes
84.7 94.1 123.1
Symptoms, signs and abnormal clinical
and laboratory findings, not elsewhere
classified
23.7 85.0 16.7
Diseases of the digestive system 45.9 46.7 67.5
Diseases of the respiratory system 31.7 29.6 38.9
Fig. 1. Number of patients treated in the reimbursement system for outpa-
tient treatment in Latvia, 2008–2011 (Anonymous, 2012).
Fig. 2. Number of patients treated in the reim-
bursement system for outpatient treatment by
the ten biggest diagnoses groups in Latvia,
2009–2011 (Anonymous, 2012).
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RESULTS
The World Health Organisation in the Report of a Joint
WHO/FAO Expert Consultation “Diet, Nutrition and the
Prevention of Chronic Diseases”, 2003, indicated that
chronic diseases are largely preventable diseases. Although
more basic research may be needed on some aspects of the
mechanisms that link diet to health, the available scientific
evidence provides a sufficiently strong and plausible role of
prevention. Beyond the appropriate medical treatment for
those already affected, the public health approach of pri-
mary prevention is considered to be the most cost-effective,
affordable and sustainable course of action to cope with the
chronic disease epidemic worldwide. The above mentioned
report reviewed the evidence on the effects of diet and nu-
trition on chronic diseases and made recommendations for
public health policies and strategies that encompass socie-
tal, behavioural and ecological dimensions. In setting out
ways to decrease the burden of chronic diseases (such as
obesity, type 2 diabetes, cardiovascular diseases (including
hypertension and stroke), cancer, dental diseases and osteo-
porosis), the report proposed that nutrition should be placed
at the forefront of public health policies and programmes.
In the present study, a literature review provided sufficient
evidence that the largest part of the reimbursed diagnoses in
Latvia are nutrition-related diseases (in the following list
the directly nutrition-related diagnoses are marked in bold
and the indirectly nutrition-related diagnoses in italic):
I. Specific infectious and parasitic diseases
II. Neoplasms
III. Diseases of the blood and blood-forming organs and
certain disorders involving the immune mechanism
IV. Endocrine, nutritional and metabolic diseases
V. Mental and behavioural disorders
VI. Diseases of the nervous system
VII. Diseases of the eye and adnexa
VIII. Diseases of the ear and mastoid process
IX. Diseases of the circulatory system
X. Diseases of the respiratory system
XI. Diseases of the digestive system
XII. Diseases of the skin and subcutaneous tissue
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Fig. 4. State budget recourses allocated for the reimbursement system and
patients’ co-payment in Latvia, 2007–2011 (Anonymous, 2012).
Fig. 3. Health care budget expenditure by
groups of diagnoses in Latvia, 2011 (Anony-
mous, 2012).
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XIII. Diseases of the musculoskeletal system and
connective tissue
XIV. Diseases of the genitourinary system
XV. Pregnancy, childbirth and the puerperium
XVI. Specific conditions originating in the perinatal
period
XVII. Congenital malformations, deformations and
chromosomal abnormalities
XVIII. Injury, poisoning and certain other consequences of
external causes
XIX Factors influencing health status and contact with
health services
The diagnosis of diabetes mellitus, as an example, justifies
the approach of the direct and indirect relation with nutri-
tion.
There are two main types of diabetes mellitus:
• Type 1 diabetes (T1DM) usually develops in childhood
and adolescence and patients require lifelong insulin in-
jections for survival;
• Type 2 diabetes (T2DM) usually develops in adulthood
and is related to obesity, lack of physical activity, and un-
healthy diets. This is the more common type of diabetes
(representing 90% of diabetic cases worldwide (Diabetes
Programme, WHO, 2012), as well as in Latvia (Anony-
mous, 2012g) and treatment may involve lifestyle
changes and weight loss alone, or oral medications or
even insulin injections.
In Latvia the direct treatment of type 2 diabetes patients
(more than 70 000 patients) consumes almost 15% of the
overall state budget for the reimbursement system (Anony-
mous, 2012g). At the same time, diabetes mellitus causes a
lot of complications, such as following (Anonymous,
2012a):
• Diabetes mellitus increases the risk of heart disease and
stroke — 50% of people with diabetes die of cardiovas-
cular disease (primarily heart disease and stroke).
• Combined with reduced blood flow, neuropathy in the
feet increases the chance of foot ulcers and eventual limb
amputation.
• Diabetic retinopathy is an important cause of blindness,
and occurs as a result of long-term accumulated damage
to the small blood vessels in the retina. After 15 years of
diabetes, approximately 2% of people become blind, and
about 10% develop severe visual impairment.
• Diabetes mellitus is among the leading causes of kidney
failure — 10–20% of people with diabetes die of kidney
failure.
• Diabetic neuropathy is damage to the nerves as a result of
diabetes, and affects up to 50% of people with diabetes
mellitus. Although many different problems can occur as
a result of diabetic neuropathy, common symptoms are
tingling, pain, numbness, or weakness in the feet and
hands.
• The overall risk of dying among people with diabetes
mellitus is at least double the risk of their peers without
diabetes mellitus.
In 2011, the treatment of diabetes mellitus complications
was ensured for 53 400 patients, there were 314 direct dis-
ability cases and 486 deaths caused by diabetes in Latvia
(Anonymous, 2012g). In the author’s opinion, the calcula-
tion of the Potential Years of Life Lost (PYLL) and Disabil-
ity-Adjusted Life Years (DALY) are the most appropriate
methods to evaluate the economic impact of this disease,
but for this purpose, data of mortality by age and gender
should be used, which are not available on the statistic data-
base websites.
Data on morbidity by groups of age and gender show that
under age of 50 years the diabetes mellitus prevalence is
higher for males, but beginning from 50 years the morbidity
sufficiently increases with higher prevalence for females.
The number of patients is particularly high in the 70–
80-year age group of (Anonymous, 2012b). According to
provisional results of the Central Statistic Bureau, the aver-
age life expectancy of inhabitants will rise (Anonymous,
2012b), and taking into account the population age structure
(Fig. 5), an increase in the number of patients needed to
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Fig. 5. Life expectancy at birth in Latvia,
2000–2010, and forecasts (Anonymous,
2011).
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treat is forecast not only for diabetes mellitus, but also for
the other chronic diseases.
In these circumstances the search and assessment of alterna-
tive treatments, based on prevention, become important.
DISCUSSION
The author, by analysis of the medicine reimbursement sys-
tem from allocative and technical efficiency points of view,
notes that there has been a trend towards technical effi-
ciency, rather than overall economic efficiency (Fig. 6).
Figure 6 is based on the classic framework of the Farrell
model, which makes it possible to decompose overall effi-
ciency into technical and allocative efficiency. The output
of the model is the treated patient, which is the outcome of
two input variables (medicines, alternatives). Under the as-
sumption that the production function is linearly homoge-
neous, the efficient unit isoquant shows all technically effi-
cient combinations. In circumstances of a limited budget,
represented by isocost line A1A2, the reimbursement result
point is located at point S on line A1A2, which insures
allocative efficiency, but not technical and overall effi-
ciency, and therefore the patient does not receive complete
treatment. There is a tendency to attempt to achieve techni-
cal efficiency at point R by increasing the budget assigna-
tion for medicine reimbursement (isocost line B1B2), but
the treatment alternatives (nutrition programme, physician’s
time by consultation or manual therapy etc.) are not evalu-
ated sufficiently. It should be taken into into account that
the overall economic efficiency would be achieved by the
evaluation and wider use of the alternatives (point Q on line
A1A2). Any point on the isoquant line has technical effi-
ciency, but only Q receives technical efficiency at minimum
cost, by combination with allocative efficiency, to achieve
the overall efficiency — the product of technical and
allocative efficiency.
In the author’s view, at least for individual reimbursement
in the case when standard medicine therapy does not
achieve the desired therapeutic effect, both the relative ef-
fectiveness of comparable medicines and other health tech-
nology assessment should be considered. In accordance
with the International Society for Pharmacoeconomics and
Outcomes Research, the goal of health technology assess-
ment (HTA) is to provide policymakers with information on
policy alternatives. Health care technology within the con-
cept of HTA is defined broadly as consisting of medicines,
biologicals, devices, equipment, supplies, medical and sur-
gical procedures, support systems, organisational, delivery
and managerial systems (Anonymous, 2003). For example,
in the United Kingdom, competent authorities carry out
complex HTA, which includes medicines, medical devices,
vaccinations, screening programmes, medical staff services,
procedures and public health programmes (Garrido et al.,
2008). In Latvia, the evaluation of the economic efficiency
is centered on assessment of medicines and medical de-
vices, but there is not a competent authority for evaluation
of the comparative efficiency of all applicable health tech-
nologies.
The essential role of the alternatives, for example, in the
case of above mentioned type 2 diabetes, is justified by sev-
eral randomised controlled trials (RCT), which show that
lifestyle interventions based on diet and exercises, reduce
the proportion of people with glucose tolerance that would
otherwise develop T2DM. The results of RCT collected and
evaluated in an academic dissertation on Assessment of
Risk and Prevention of Type 2 Diabetes in Primary Health
Care (Saaristo, 2011) showed that the 1–6 years incidence
of diabetes was reduced in lifestyle trials by 30–60% com-
pared with a control group. At the same time, the prevent-
able use of Metforminum without lifestyle interventions
showed less than 30% relative risk reduction of T2DM. Fol-
low-up studies of the major lifestyle trials in prevention of
type 2 diabetes in seven-year period showed a relative risk
reduction of T2DM by 34–43%, compared to the control
group. Thus, these trials showed that T2DM can be pre-
vented or delayed by lifestyle interventions. In scope of
above mentioned academic dissertation, the effect of life-
style interventions on weight and its association with glu-
cose tolerance was evaluated in individuals at high risk for
diabetes in a one-year follow-up. In total 17.5% of them lost
more than 5% of weight. Their relative risk for diabetes de-
creased 69% compared with the group that maintained their
weight (Saaristo, 2011).
Coming back to the issue of the limited budget and patient
resources for the medicines reimbursement system, in the
author’s opinion a discussable question is also, data from
the Central Statistical Bureau of Latvia that shows, based on
the composition and structure of average consumption ex-
penditure per household member, one third of the income of
Latvian inhabitants is spent for food (Anonymous, 2012e).
Thus, the rational diet is both the potential for disease pre-
vention and saving resources for a healthy lifestyle.
The main conclusions of this research are following:
- The largest number of reimbursed diagnoses, such as car-
diovascular diseases, diabetes, cancer, digestive diseases,
osteoporosis, are identified as nutrient-related diagnoses by
a special literature review.
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Fig. 6. Allocative, technical and overall efficiency in health care (Anony-
mous, 2008).
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- The nutrient-related diagnoses contribute more than half
of the state budget resources allocated to the reimbursement
system in Latvia.
- The budget approach could be changed from medicine-
based to an alternatives-based approach.
- There are not sufficient data to calculate indicators such as
Potential Years of Life Lost (PYLL) and Disability-Ad-
justed Life Years (DALY), which can be used in economic
assessment of treatment and preventive programmes.
- Prevention programmes for potential patients and educa-
tional programmes for patients should be encouraged.
- Data on composition and structure of consumption expen-
diture average per household member show that one-third
of income is spent for food, and thus the Hippocrates’ quote
“Let food be thy medicine and medicine be thy food” can be
important and useful also in the present epoch.
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UZTURA ATKARÎGÂS SLIMÎBAS ZÂÏU KOMPENSÂCIJAS SISTÇMA LATVIJÂ
Latvijâ ambulatorajai ârstçðanai paredzçto zâïu un medicînisko ierîèu iegâdes izdevumu kompensâcijas sistçma darbojas stingri ierobeþotu
valsts budþeta lîdzekïu apstâkïos, lîdz ar to aktuâls kïûst jautâjums par papildus iespçju izvçrtçðanu lîdzekïu izlietojuma optimizâcijai,
òemot vçrâ arî preventîvo pasâkumu nozîmîgumu. Pçtîjuma mçríis ir identificçt uztura atkarîgâs slimîbas zâïu iegâdes izdevumu
kompensâcijas sistçmâ un novçrtçt iespçjas noteikt papildinoðo uztura programmu potenciâlo efektivitâti. Mçría sasniegðanai izmantotas
teorçtiskâs izpçtes metodes (normatîvo dokumentu un speciâlâs literatûras analîze) un empîriskâs izpçtes metodes (statistikas datu vâkðana,
apkopoðana un analîze). Pçtîjuma rezultâti liecina par to, ka lielâkâ daïa kompensçjamo diagnoþu, tâdas kâ sirds un asinsvadu slimîbas,
diabçts, onkoloìiskâs slimîbas, gremoðanas sistçmas slimîbas, osteoporoze, ir uztura atkarîgâs slimîbas, un tâm tiek izlietota vairâk kâ puse
zâïu kompensâcijas sistçmai atvçlçtâ budþeta. Turklât ir virkne slimîbu, kas ir netieði atkarîgas no uztura, bet tâs rodas kâ uztura atkarîgo
slimîbu izraisîtâs komplikâcijas. Uz pierâdîjumiem balstîtâs medicînas laikmetâ îpaði aktuâla kïûst ârstçðanas un preventîvo pasâkumu
ekonomiskâs efektivitâtes novçrtçðana. Speciâlajâ literatûrâ ir dati par uztura programmu pozitîvo nozîmi smagu slimîbu novçrðanâ vai
ietekmes mazinâðanâ, tomçr jâatzîmç, ka nav izstrâdâta precîza metodoloìija, kas ïautu veikt medikamentozâs ârstçðanas un preventîvo
pasâkumu salîdzinoðo ekonomiskâs efektivitâtes novçrtçðanu, lai sagatavotu ar pierâdîjumiem pamatotu informâciju lçmumu pieòemðanai
par lîdzekïu sadali. Lîdz ar to ðis ir turpmâkâs izpçtes objekts.
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